The discovery, synthesis, potential binding mode, and in vitro kinase profile of 3-(3-bromo-4- hydroxy-5-(2′-methoxyphenyl)-benzylidene)-5-bromo-1, 3-dihydro-pyrrolo [2, 3-b] pyridin-2- one, 3-[(1-methyl-1H-indol-3-yl) methylene]-1, 3-dihydro-2H-pyrrolo [3, 2-b]-pyridin-2-one as potent TrkA inhibitors are discussed.